FMT

FMT

2901 bookmarks
Custom sorting
Fecal microbiota transplanted from old mice promotes more colonic inflammation, proliferation, and tumor formation in azoxymethane-treated A/J mice than microbiota originating from young mice - PubMed
Fecal microbiota transplanted from old mice promotes more colonic inflammation, proliferation, and tumor formation in azoxymethane-treated A/J mice than microbiota originating from young mice - PubMed
Aging is a strong risk factor for colorectal cancer (CRC). It is well established that gut microbial dysbiosis can play a role in the etiology of CRC. Although the composition of the gut microbial community changes with age and is reported to become more pro-inflammatory, it is unclear whether such …
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplanted from old mice promotes more colonic inflammation, proliferation, and tumor formation in azoxymethane-treated A/J mice than microbiota originating from young mice - PubMed
The Role of the Gut Microbiome in Cancer: A Review, With Special Focus on Colorectal Neoplasia and Clostridioides difficile - PubMed
The Role of the Gut Microbiome in Cancer: A Review, With Special Focus on Colorectal Neoplasia and Clostridioides difficile - PubMed
The gut microbiome has coevolved with humans to aid in physiologic functions and prevent disease. An increasing prevalence of gut dysbiosis in modern society exists and has strong linkages to multiple disease processes common in the developed world. Mechanisms for microbiome-human interactions that …
·pubmed.ncbi.nlm.nih.gov·
The Role of the Gut Microbiome in Cancer: A Review, With Special Focus on Colorectal Neoplasia and Clostridioides difficile - PubMed
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence - PubMed
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence - PubMed
Live biotherapeutic products (LBPs) represent a new class of therapeutics indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in adults. However, microbiota-based therapies have been used in CDI management before the Food and Drug Administration (FDA) designated this new …
·pubmed.ncbi.nlm.nih.gov·
Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence - PubMed
Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention - PubMed
Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention - PubMed
The profound impact of the human microbiome on health and disease has captivated the interest of clinical and scientific communities. The human body hosts a vast array of microorganisms collectively forming the human microbiome, which significantly influences various physiological processes and prof …
·pubmed.ncbi.nlm.nih.gov·
Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention - PubMed
Where are we on microbiome-based therapies in disorders of gut-brain interaction?
Where are we on microbiome-based therapies in disorders of gut-brain interaction?
Highlights from NeuroGASTRO 2023. Find out about the main takeaways from the role of fecal microbiota transplants, microbial consortia and probiotics in disorders of gut-brain interaction picked up by GMFH editors (Part 2).
·news.google.com·
Where are we on microbiome-based therapies in disorders of gut-brain interaction?
Fecal Microbiota Transplantation: Information for the Pediatrician
Fecal Microbiota Transplantation: Information for the Pediatrician
Fecal microbiota transplantation (FMT) involves the delivery of an entire microbial community from a healthy donor to a recipient with the intention of ameliorating or curing a specific disease. Current evidence strongly supports a role for FMT in the treatment of Clostridiodes difficile infection, with cure rates of approximately 80%...
·news.google.com·
Fecal Microbiota Transplantation: Information for the Pediatrician
Protocol summary and statistical analysis plan for the Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients (SuDDICU) crossover, cluster randomised controlled trial - PubMed
Protocol summary and statistical analysis plan for the Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients (SuDDICU) crossover, cluster randomised controlled trial - PubMed
Background: It is unclear whether the use of selective decontamination of the digestive tract (SDD) improves outcomes in ventilated patients in intensive care units (ICUs) and whether SDD is associated with the development of antibiotic resistance. Objective: To describe the study prot …
·pubmed.ncbi.nlm.nih.gov·
Protocol summary and statistical analysis plan for the Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients (SuDDICU) crossover, cluster randomised controlled trial - PubMed
The human microbiome project at ten years - some critical comments and reflections on "our third genome", the human virome - PubMed
The human microbiome project at ten years - some critical comments and reflections on "our third genome", the human virome - PubMed
The Human Microbiome Project (HMP) has raised great expectations claiming the far-reaching influence of the microbiome on human health and disease ranging from obesity and malnutrition to effects going well beyond the gut. So far, with the notable exception of fecal microbiota transplantation in …
·pubmed.ncbi.nlm.nih.gov·
The human microbiome project at ten years - some critical comments and reflections on "our third genome", the human virome - PubMed
The human microbiome project at ten years - some critical comments and reflections on "our third genome", the human virome - PubMed
The human microbiome project at ten years - some critical comments and reflections on "our third genome", the human virome - PubMed
The Human Microbiome Project (HMP) has raised great expectations claiming the far-reaching influence of the microbiome on human health and disease ranging from obesity and malnutrition to effects going well beyond the gut. So far, with the notable exception of fecal microbiota transplantation in …
·pubmed.ncbi.nlm.nih.gov·
The human microbiome project at ten years - some critical comments and reflections on "our third genome", the human virome - PubMed
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study - PubMed
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study - PubMed
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study
·pubmed.ncbi.nlm.nih.gov·
Epidemiology, outcomes and risk factors for recurrence of Clostridioides difficile infections following allogeneic hematopoietic cell transplantation: a longitudinal retrospective multicenter study - PubMed
The value of oral microbiome therapy for recurrent C. difficile infection
The value of oral microbiome therapy for recurrent C. difficile infection
A trial assessed a microbiome therapeutic composed of purified Firmicutes spores for the treatment of recurrent C. diff infection. Read IDSA’s Journal Club review by Zeina Kanafani MD, MS, CIC, FIDSA.
·news.google.com·
The value of oral microbiome therapy for recurrent C. difficile infection
Unraveling the Gut-Brain Axis in Multiple Sclerosis: Exploring Dysbiosis, Oxidative Stress, and Therapeutic Insights - PubMed
Unraveling the Gut-Brain Axis in Multiple Sclerosis: Exploring Dysbiosis, Oxidative Stress, and Therapeutic Insights - PubMed
This comprehensive review delves into the intricate relationship between the gut microbiota and multiple sclerosis (MS), shedding light on the potential therapeutic avenues for this complex autoimmune disease. It emphasizes the multifactorial nature of MS, including genetic, environmental, and gende …
·pubmed.ncbi.nlm.nih.gov·
Unraveling the Gut-Brain Axis in Multiple Sclerosis: Exploring Dysbiosis, Oxidative Stress, and Therapeutic Insights - PubMed
Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances - PubMed
Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances - PubMed
Inflammatory bowel disease (IBD) is a chronic and idiopathic condition that results in inflammation of the gastrointestinal tract, leading to conditions such as ulcerative colitis and Crohn's disease. Commonly used treatments for IBD include anti-inflammatory drugs, immunosuppressants, and antibioti …
·pubmed.ncbi.nlm.nih.gov·
Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances - PubMed
Vitamin K1 ameliorates lipopolysaccharide-triggered skeletal muscle damage revealed by faecal bacteria transplantation - PubMed
Vitamin K1 ameliorates lipopolysaccharide-triggered skeletal muscle damage revealed by faecal bacteria transplantation - PubMed
Vitamin K1 might ameliorate LPS-triggered skeletal muscle damage by antagonizing NF-κB-mediated inflammation through upregulation of SIRT1 and regulating the balance between protein synthesis and catabolism.
·pubmed.ncbi.nlm.nih.gov·
Vitamin K1 ameliorates lipopolysaccharide-triggered skeletal muscle damage revealed by faecal bacteria transplantation - PubMed
Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215) - PubMed
Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215) - PubMed
This study was supported by the National Natural Science Foundation of China (82102954 to Wensi Zhao) and the Special Project of Central Government for Local Science and Technology Development of Hubei Province (ZYYD2020000169 to Yongshun Chen).
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation plus tislelizumab and fruquintinib in refractory microsatellite stable metastatic colorectal cancer: an open-label, single-arm, phase II trial (RENMIN-215) - PubMed
The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review - PubMed
The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review - PubMed
Gut microbiome dysbiosis may be implicated in numerous diseases. Substantial evidence suggests FMT improves clinical outcomes for certain indications, but evidence quality varies greatly depending on the specific indication, route of administration, frequency of instillation, fecal preparation, and …
·pubmed.ncbi.nlm.nih.gov·
The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review - PubMed
Fecal microbiota transplantation as a therapy for treating ulcerative colitis: an overview of systematic reviews - PubMed
Fecal microbiota transplantation as a therapy for treating ulcerative colitis: an overview of systematic reviews - PubMed
In conclusion, moderate- to high-quality evidence supported a promising use of FMT to safely induce remission in UC. However, further trials with larger sample size are still required to comprehensively analyze the delivery route, total dosage, frequency, and donor selection in FMT.
·pubmed.ncbi.nlm.nih.gov·
Fecal microbiota transplantation as a therapy for treating ulcerative colitis: an overview of systematic reviews - PubMed
Clinical potential of microbiota in thyroid cancer therapy - PubMed
Clinical potential of microbiota in thyroid cancer therapy - PubMed
Thyroid cancer is one of the most common tumors of the endocrine system because of its rapid and steady increase in incidence and prevalence. In recent years, a growing number of studies have identified a key role for the gut, thyroid tissue and oral microbiota in the regulation of metabolism and th …
·pubmed.ncbi.nlm.nih.gov·
Clinical potential of microbiota in thyroid cancer therapy - PubMed
Horizontal transmission of gut microbiota attenuates mortality in lung fibrosis - PubMed
Horizontal transmission of gut microbiota attenuates mortality in lung fibrosis - PubMed
Pulmonary fibrosis is a chronic and often fatal disease. The pathogenesis is characterized by aberrant repair of lung parenchyma resulting in loss of physiological homeostasis, respiratory failure and death. The immune response in pulmonary fibrosis is dysregulated. The gut microbiome is a key regul …
·pubmed.ncbi.nlm.nih.gov·
Horizontal transmission of gut microbiota attenuates mortality in lung fibrosis - PubMed
Esketamine mitigates cognitive impairment following exposure to LPS by modulating the intestinal flora/subdiaphragmatic vagus nerve/spleen axis - PubMed
Esketamine mitigates cognitive impairment following exposure to LPS by modulating the intestinal flora/subdiaphragmatic vagus nerve/spleen axis - PubMed
The intestinal flora/subdiaphragmatic vagus nerve/spleen axis-mediated hippocampal BDNF downregulation significantly affected secondary LPS-induced systemic inflammation and cognitive dysfunction. Esketamine preserves cognitive function via this mechanism.
·pubmed.ncbi.nlm.nih.gov·
Esketamine mitigates cognitive impairment following exposure to LPS by modulating the intestinal flora/subdiaphragmatic vagus nerve/spleen axis - PubMed
Palmitic acid and trans-4-hydroxy-3-methoxycinnamate, the active ingredients of Yaobishu formula, reduce inflammation and pain by regulating gut microbiota and metabolic changes after lumbar disc herniation to activate autophagy and the Wnt/β-catenin pathway - PubMed
Palmitic acid and trans-4-hydroxy-3-methoxycinnamate, the active ingredients of Yaobishu formula, reduce inflammation and pain by regulating gut microbiota and metabolic changes after lumbar disc herniation to activate autophagy and the Wnt/β-catenin pathway - PubMed
The imbalance in gut microbiota triggers an inflammatory response that spreads from the gut to the discs and is associated with lumbar disc herniation (LDH). In this study, we investigated the mechanism of palmitic acid (PA) and trans-4-hydroxy-3-methoxycinnamic acid (THMC) on microbiota, metabolic …
·pubmed.ncbi.nlm.nih.gov·
Palmitic acid and trans-4-hydroxy-3-methoxycinnamate, the active ingredients of Yaobishu formula, reduce inflammation and pain by regulating gut microbiota and metabolic changes after lumbar disc herniation to activate autophagy and the Wnt/β-catenin pathway - PubMed
Trasplantes de microbiota fecal para tratar «Clostridioides difficile»
Trasplantes de microbiota fecal para tratar «Clostridioides difficile»
La American Academy of Pediatrics respaldó los trasplantes fecales para eliminar la infección por «Clostridioides difficile» en los niños y pidió más investigación sobre otros usos.
·news.google.com·
Trasplantes de microbiota fecal para tratar «Clostridioides difficile»
Repurposing dried blood spot (DBS) device technology to examine bile acid profiles in human dried fecal spot (DFS) samples - PubMed
Repurposing dried blood spot (DBS) device technology to examine bile acid profiles in human dried fecal spot (DFS) samples - PubMed
Dried blood spot (DBS) analysis has existed for 50 years, but application of this technique to fecal analysis remains limited. To address whether dried fecal spots (DFS) could be used to measure fecal bile acids, we collected feces from five subjects for each of the following cohorts: i) healthy …
·pubmed.ncbi.nlm.nih.gov·
Repurposing dried blood spot (DBS) device technology to examine bile acid profiles in human dried fecal spot (DFS) samples - PubMed
Axin1's mystique in manipulating microbiome amidst colitis - PubMed
Axin1's mystique in manipulating microbiome amidst colitis - PubMed
Classically, Axin1 is considered a regulator of Wnt/β-catenin signaling. However, Axin1's roles in host-microbial interactions have been unknown. Our recent study has demonstrated that deletion of intestinal epithelial Axin1 in epithelial cells and Paneth cells protects the host against colitis by e …
·pubmed.ncbi.nlm.nih.gov·
Axin1's mystique in manipulating microbiome amidst colitis - PubMed
Role of Baseline Gut Microbiota on Response to Fiber Intervention in Individuals with Irritable Bowel Syndrome - PubMed
Role of Baseline Gut Microbiota on Response to Fiber Intervention in Individuals with Irritable Bowel Syndrome - PubMed
Irritable bowel syndrome (IBS) is one of the most prevalent functional gut disorders in the world. Partially hydrolyzed guar gum, a low-viscosity soluble fiber, has shown promise in the management of IBS-related symptoms. In this study, we aimed to determine if an individual's baseline gut microbiot …
·pubmed.ncbi.nlm.nih.gov·
Role of Baseline Gut Microbiota on Response to Fiber Intervention in Individuals with Irritable Bowel Syndrome - PubMed